n(g)-nitroarginine-4-nitroanilide has been researched along with Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rice, AS | 1 |
| Babbedge, RC; Gaffen, ZA; Hart, SL; Moore, PK; Wallace, P | 1 |
2 other study(ies) available for n(g)-nitroarginine-4-nitroanilide and Pain
| Article | Year |
|---|---|
Topical spinal administration of a nitric oxide synthase inhibitor prevents the hyper-reflexia associated with a rat model of persistent visceral pain.
Topics: Amino Acid Oxidoreductases; Analgesics; Anilides; Animals; Arginine; Cystitis; Female; Injections, Spinal; Nitric Oxide Synthase; Pain; Rats; Rats, Wistar; Reflex; Reflex, Abnormal; Turpentine; Urinary Bladder; Viscera | 1995 |
L-NG-nitro arginine p-nitroanilide (L-NAPNA) is anti-nociceptive in the mouse.
Topics: Amino Acid Oxidoreductases; Analgesics; Anilides; Animals; Aorta, Thoracic; Arginine; Blood Pressure; Brain; Formaldehyde; In Vitro Techniques; Male; Mice; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; omega-N-Methylarginine; Pain; Rabbits; Rats; Rats, Sprague-Dawley | 1993 |